Skip to main content

Oncorus, Inc.

ONCRDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001671818

Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Oncorus, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ONCR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4540−5
Shares17.0M16.5M−455.7K (−2.7%)
Value$21.4M$14.1M−$7.36M (−34.4%)

New holders (3)

Institutions that held Oncorus, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ONCR in Q3 2022
InstitutionSharesValue% of portfolio
Assenagon Asset Management S.A.13,642$12.0K0.00%
BNP Paribas Arbitrage, SA905$7690.00%
China Universal Asset Management Co., Ltd.243$00.00%

Sold out (8)

Institutions that held Oncorus, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ONCR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Private Advisor Group, LLC81,304$103.0K
Susquehanna International Group, LLP41,192$52.0K
Cubist Systematic Strategies, LLC10,868$14.0K
Legal & General Group Plc1,629$2.00K
New York State Common Retirement Fund203$0
Credit Suisse AG11$0
Simplex Trading, LLC605$0
Capital Advisors, Ltd. LLC121$0